Search Orphan Drug Designations and Approvals
-
Generic Name: | N-{[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide |
---|---|
Date Designated: | 02/04/2011 |
Orphan Designation: | Treatment of tuberculosis. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Sequella, Inc. 9610 Medical Center Drive Suite 200 Rockville, Maryland 20820 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-